INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

  • Why Real-Time eCOA Data Matters More Than Ever
    10/16/2025

    Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.

  • Changing The Clinical Feasibility Game With AI
    1/22/2026

    AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.

  • Why Early RTSM Involvement Matters
    3/25/2026

    Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.

  • The New Reality Of Clinical Trial Payment Workflows
    7/13/2026

    Outdated trial payment processes create costly delays. Explore strategies for centralized financial management, participant reimbursement, and improved study execution.

  • Taming The Complex Clinical-Trial Ecosystem
    4/9/2025

    To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.

CLINICAL TRIAL TECHNOLOGY SOLUTIONS

  • Biotech companies progressing through clinical trials, planning an IPO, and undergoing rapid growth have a unique set of financial, contract, compliance, and reporting needs. We have designed an ERP solution, built on NetSuite, to address all of these needs. With over 50 implementations in the last two years alone, SuiteSuccess for Life Sciences is quickly becoming the defacto software standard for all successful biotechnology companies.

  • Improve study quality, accelerate decision making, and reduce site and sponsor burden by using IQVIA’s integrated Interactive Response Technology and electronic Clinical Outcome Assessment solution.

  • With nearly three decades of successful application, NeuroCart remains a gold standard in CNS pharmacology, supporting precise, data-driven decisions in drug development.

  • Studies show when participants are informed and comfortable with the consent process, they're more likely to comply with protocol, remain enrolled, and contribute to faster study deployment.

  • Achieve complete financial visibility, eliminate complexity, and ensure the financial health of your clinical trials with Rave Clinical Trial Financial Management.